OsterG, HuseDM, LaceyMJ, ReganMM, FuchsHJ. Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosis. Ann Pharmacother1995;29:459-64.
2.
FuchsHJ, BorowitzDS, ChristiansenDH, MorrisEM, NashML, RamseyBW,. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl I Med1994;331:637-42.
